The Antibody Society

the official website of the antibody society

The Antibody Society

An international non-profit supporting antibody-related research and development.

  • About
    • Mission & Activities
    • Board of Directors
    • Staff & Editors
    • Advisors
    • Sponsors
  • Society meetings
    • Antibody Engineering & Therapeutics (US)
      • 2018 Antibody Engineering & Therapeutics
      • Keynote presentations
      • What is INN a Name?
        • INN issue updates
    • Antibody Engineering & Therapeutics Europe
    • AIRR Community Meetings
    • FOCIS Symposia
    • Society-Funded Meetings
  • AIRR Community
    • AIRR News
    • AIRR Meetings
      • AIRR Community Meeting IV
      • AIRR Community Meeting III
        • Day 1
        • Day 2
        • Day 3
        • Day 4
      • AIRR Community Meeting II
    • AIRR Working Groups
      • Biological Reagents Working Group
      • Common Repository Working Group
      • Data Representation Working Group
      • Minimal Standards Working Group
      • Software Working Group
      • Germline Database Working Group
    • AIRR Subcomittees
      • Communications Sub-committee
      • Meeting Sub-committee
      • Inferred Allele Review Committee
  • Become a member
    • Membership Levels
  • Members only
    • Login
    • Note to members
    • Antibodies to watch
    • Approved antibodies
    • Meeting reports
    • Presentations
  • Upcoming meetings
  • Web Resources
    • Research Resources
    • Education Resources
    • Career Resources
  • Jobs
You are here: Home / Archives for Nobel prize

Congratulations to Sir Greg Winter, Nobel laureate!

October 4, 2018 by Zita Schneider

Sir Gregory P. Winter (MRC Laboratory of Molecular Biology, Cambridge, UK) was named Nobel Laureate by The Royal Swedish Academy of Sciences on October 3, 2018 “for the phage display of peptides and antibodies”. He shares the Nobel Prize in Chemistry with Frances H. Arnold (California Institute of Technology, CA, US) and George P. Smith (University of Missouri-Columbia, US). More information about the Nobel Prize can be found here.

Sir Greg Winter’s work on phage display and humanization of antibodies revolutionized the field and led to the approval of the first phage display-derived antibody, adalimumab (1). Although new methodologies have been used and implemented, phage display (2, 3) and humanization remain among the most important techniques used to drive antibody discovery and development of antibody-based therapeutics.

The Antibody Society is proud to have Sir Greg Winter among its scientific advisors.

References:
1. Guiding the Selection of Human Antibodies from Phage Display Repertoires to a Single Epitope of an Antigen
2. Phage display-derived human antibodies in clinical development and therapy
3. Drugs derived from phage display

Filed Under: Antibody discovery Tagged With: Nobel prize

MEMBER LOGIN

MEMBER LOGIN

Members, please login here to access content in the Members Only section!

WEBSITE SEARCH

Recent Posts

  • New antibody-drug conjugate, polatuzumab vedotin, enters FDA review February 20, 2019
  • Most read from mAbs, Feb/March 2019 February 15, 2019
  • FDA approval for caplacizumab-yhdp February 6, 2019

AIRR Community

AIRR Community

The Adaptive Immune Receptor Repertoire Community is a research-driven group organizing around the use of high-throughput sequencing technologies to study antibody/B-cell and T-cell receptor repertoires.

MABS

MABS

mAbs publishes on all topics relevant to antibody research and development. The Antibody Society members receive a special annual subscription rate of US $84 for online only access!

PEDS

PEDS

Archives

Follow us online

  • Email
  • Facebook
  • Linkedin
  • Twitter
  • Home
  • Privacy & Terms
  • About
  • Board of Directors
  • Advisors
  • Sponsors
  • Mission & Activities
  • Join the Society
  • Membership levels
  • Members only
  • Login
  • Approved antibodies
  • Meeting reports
  • Presentations
  • Contact

©2015 - scicomvisuals